BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US09064C2061

Price
7.20 USD
Market cap
239.09 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

BIOFORCE NANOSCIENCES HOLDINGS, INC. financials

Fiscal year2025
EBIT-1.29 m USD
Net income-1.29 m USD
Diluted EPS – continuing operations-0.04 USD

Full history since 2002, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About BIOFORCE NANOSCIENCES HOLDINGS, INC.

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.